KALA BIO, Inc
KALA BIO, Inc. is a clinical-stage biopharmaceutical company based in Arlington, MA, dedicated to addressing rare and serious eye diseases through innovative therapies. Utilizing their proprietary mesenchymal stem cell secretome (MSC-S) platform, the company is developing treatments aimed at preserving vision and enhancing the quality of life for patients with challenging ocular conditions.
The company's notable pipeline includes KPI-012, a topical therapy currently in Phase 2b clinical study for persistent corneal epithelial defect, and KPI-014, an intravitreal therapy in preclinical development for inherited retinal diseases. Having secured FDA approval for two ophthalmic products, KALA BIO is now focusing on biologics to further its mission of transforming the treatment landscape for ophthalmic diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
